These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22456733)

  • 1. The role of ATM in response to metformin treatment and activation of AMPK.
    Woods A; Leiper JM; Carling D
    Nat Genet; 2012 Mar; 44(4):360-1. PubMed ID: 22456733
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of ATM in response to metformin treatment and activation of AMPK.
    Zhou K; Bellenguez C; Sutherland C; Hardie G; Palmer C; Donnelly P; Pearson E
    Nat Genet; 2012 Mar; 44(4):361-2. PubMed ID: 22456734
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of ATM in response to metformin treatment and activation of AMPK.
    Yee SW; Chen L; Giacomini KM
    Nat Genet; 2012 Mar; 44(4):359-60. PubMed ID: 22456732
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Martin-Castillo B; Menendez JA
    Cell Cycle; 2011 May; 10(9):1499-501. PubMed ID: 21566461
    [No Abstract]   [Full Text] [Related]  

  • 5. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
    ; ; Zhou K; Bellenguez C; Spencer CC; Bennett AJ; Coleman RL; Tavendale R; Hawley SA; Donnelly LA; Schofield C; Groves CJ; Burch L; Carr F; Strange A; Freeman C; Blackwell JM; Bramon E; Brown MA; Casas JP; Corvin A; Craddock N; Deloukas P; Dronov S; Duncanson A; Edkins S; Gray E; Hunt S; Jankowski J; Langford C; Markus HS; Mathew CG; Plomin R; Rautanen A; Sawcer SJ; Samani NJ; Trembath R; Viswanathan AC; Wood NW; ; Harries LW; Hattersley AT; Doney AS; Colhoun H; Morris AD; Sutherland C; Hardie DG; Peltonen L; McCarthy MI; Holman RR; Palmer CN; Donnelly P; Pearson ER
    Nat Genet; 2011 Feb; 43(2):117-20. PubMed ID: 21186350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics: Drugs, diabetes and cancer.
    Birnbaum MJ; Shaw RJ
    Nature; 2011 Feb; 470(7334):338-9. PubMed ID: 21331030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highlights from the latest pharmacogenomic genome-wide association studies.
    Mlakar V; Marc J
    Pharmacogenomics; 2013 Mar; 14(4):357-60. PubMed ID: 23438881
    [No Abstract]   [Full Text] [Related]  

  • 8. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Taylor A; Mather K; Horton E; White NH; Barrett-Connor E; Knowler WC; Shuldiner AR; Pollin TI;
    Diabetes Care; 2012 Sep; 35(9):1864-7. PubMed ID: 22751958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of ATM hypermethylation in mantle cell and follicular lymphoma.
    Chim CS; Wong KY; Loong F; Srivastava G
    Leukemia; 2005 May; 19(5):880-2. PubMed ID: 15744354
    [No Abstract]   [Full Text] [Related]  

  • 10. A role for ATM in hereditary pancreatic cancer.
    Bakker JL; de Winter JP
    Cancer Discov; 2012 Jan; 2(1):14-5. PubMed ID: 22585162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM polymorphism is associated with low risk myelodysplastic syndrome.
    Ribeiro HL; Oliveira RT; Maia AR; Sousa JC; Heredia FF; Magalhães SM; Pinheiro RF
    DNA Repair (Amst); 2013 Feb; 12(2):87-9. PubMed ID: 23246256
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks.
    Lee JH; Paull TT
    Oncogene; 2007 Dec; 26(56):7741-8. PubMed ID: 18066086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.
    Carter A; Lin K; Sherrington PD; Atherton M; Pearson K; Douglas A; Burford A; Brito-Babapulle V; Matutes E; Catovsky D; Pettitt AR
    Leukemia; 2006 Apr; 20(4):737-40. PubMed ID: 16437137
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of AMP-activated protein kinase in cerebella of Atm-/- mice is attributable to accumulation of reactive oxygen species.
    Kuang X; Yan M; Ajmo JM; Scofield VL; Stoica G; Wong PK
    Biochem Biophys Res Commun; 2012 Feb; 418(2):267-72. PubMed ID: 22260947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer.
    Langholz B; Bernstein JL; Bernstein L; Olsen JH; Børresen-Dale AL; Rosenstein BS; Gatti RA; ; Concannon P
    Int J Cancer; 2006 Aug; 119(3):724-5. PubMed ID: 16496408
    [No Abstract]   [Full Text] [Related]  

  • 16. How important is ATM?
    Lavin MF
    Radiat Res; 2005 Jun; 163(6):704. PubMed ID: 16044504
    [No Abstract]   [Full Text] [Related]  

  • 17. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
    Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
    Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel mutation in the ATM gene in a Malian family with ataxia telangiectasia.
    Landouré G; Mochel F; Meilleur K; Ly M; Sangaré M; Bocoum N; Bagayoko K; Coulibaly T; Sarr AM; Bâ HO; Coulibaly S; Guinto CO; Touré M; Traoré M; Fischbeck KH
    J Neurol; 2013 Jan; 260(1):324-6. PubMed ID: 23142947
    [No Abstract]   [Full Text] [Related]  

  • 19. ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
    Gumy-Pause F; Wacker P; Maillet P; Betts DR; Sappino AP
    Leukemia; 2006 Mar; 20(3):526-7; author reply 527. PubMed ID: 16408093
    [No Abstract]   [Full Text] [Related]  

  • 20. The ATM gene and ataxia telangiectasia.
    Mavrou A; Tsangaris GT; Roma E; Kolialexi A
    Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.